Marcus Sucksdorff

838 total citations
23 papers, 501 citations indexed

About

Marcus Sucksdorff is a scholar working on Pathology and Forensic Medicine, Neurology and Oncology. According to data from OpenAlex, Marcus Sucksdorff has authored 23 papers receiving a total of 501 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pathology and Forensic Medicine, 9 papers in Neurology and 5 papers in Oncology. Recurrent topics in Marcus Sucksdorff's work include Multiple Sclerosis Research Studies (20 papers), Neuroinflammation and Neurodegeneration Mechanisms (9 papers) and Advanced Neuroimaging Techniques and Applications (5 papers). Marcus Sucksdorff is often cited by papers focused on Multiple Sclerosis Research Studies (20 papers), Neuroinflammation and Neurodegeneration Mechanisms (9 papers) and Advanced Neuroimaging Techniques and Applications (5 papers). Marcus Sucksdorff collaborates with scholars based in Finland, Switzerland and United Kingdom. Marcus Sucksdorff's co-authors include Laura Airas, Markus Matilainen, Eero Rissanen, Jouni Tuisku, Marjo Nylund, Johanna Rokka, Juha O. Rinne, Teemu Paavilainen, Maija Saraste and Jens Kühle and has published in prestigious journals such as Brain, Neurology and Journal of Neurology Neurosurgery & Psychiatry.

In The Last Decade

Marcus Sucksdorff

21 papers receiving 501 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marcus Sucksdorff Finland 12 353 172 136 116 81 23 501
Marjo Nylund Finland 10 354 1.0× 159 0.9× 135 1.0× 110 0.9× 77 1.0× 22 486
Damiano Marastoni Italy 12 278 0.8× 122 0.7× 124 0.9× 67 0.6× 49 0.6× 35 433
Paul Su United Kingdom 8 234 0.7× 188 1.1× 125 0.9× 150 1.3× 41 0.5× 13 605
Clarisse Carra‐Dallière France 13 340 1.0× 95 0.6× 292 2.1× 130 1.1× 56 0.7× 51 584
Etsuji Saji Japan 7 390 1.1× 206 1.2× 185 1.4× 128 1.1× 57 0.7× 15 712
Roumen Balabanov United States 9 185 0.5× 159 0.9× 113 0.8× 188 1.6× 64 0.8× 16 519
Signe Modvig Denmark 11 197 0.6× 75 0.4× 108 0.8× 105 0.9× 48 0.6× 26 481
Dieter Haering Switzerland 5 304 0.9× 48 0.3× 171 1.3× 101 0.9× 64 0.8× 11 459
Luisa Pastò Italy 12 357 1.0× 77 0.4× 140 1.0× 47 0.4× 38 0.5× 18 445
Miriam Tamaño‐Blanco United States 13 351 1.0× 48 0.3× 73 0.5× 126 1.1× 94 1.2× 21 534

Countries citing papers authored by Marcus Sucksdorff

Since Specialization
Citations

This map shows the geographic impact of Marcus Sucksdorff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcus Sucksdorff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcus Sucksdorff more than expected).

Fields of papers citing papers by Marcus Sucksdorff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marcus Sucksdorff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcus Sucksdorff. The network helps show where Marcus Sucksdorff may publish in the future.

Co-authorship network of co-authors of Marcus Sucksdorff

This figure shows the co-authorship network connecting the top 25 collaborators of Marcus Sucksdorff. A scholar is included among the top collaborators of Marcus Sucksdorff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marcus Sucksdorff. Marcus Sucksdorff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Radford‐Smith, Daniel, Abi G. Yates, Marjo Nylund, et al.. (2025). Integrating TSPO-PET imaging with metabolomics for enhanced prognostic accuracy in multiple sclerosis. BMJ Neurology Open. 7(1). e001026–e001026. 2 indexed citations
2.
Sucksdorff, Marcus, et al.. (2025). Sex Comparison of White-Blood-Cell Responses to Acute Vigorous-Intensity Aerobic Exercise. International Journal of Sports Physiology and Performance. 20(12). 1636–1646.
3.
Sucksdorff, Marcus, Jens Kühle, Marjo Nylund, et al.. (2025). Predictors of risk of secondary progression in multiple sclerosis. Therapeutic Advances in Neurological Disorders. 18. 4243638364–4243638364.
4.
Palomäki, Antti, et al.. (2024). Prolonged viral pneumonia and high mortality in COVID-19 patients on anti-CD20 monoclonal antibody therapy. European Journal of Clinical Microbiology & Infectious Diseases. 43(4). 723–734. 3 indexed citations
5.
Tuisku, Jouni, Marcus Sucksdorff, Marjo Nylund, et al.. (2024). P2X 7-receptor binding in new-onset and secondary progressive MS – a [11C]SMW139 PET study. EJNMMI Research. 14(1). 123–123. 2 indexed citations
6.
Saraste, Maija, Markus Matilainen, Marcus Sucksdorff, et al.. (2023). Association of serum neurofilament light with microglial activation in multiple sclerosis. Journal of Neurology Neurosurgery & Psychiatry. 94(9). 698–706. 14 indexed citations
7.
Laaksonen, Sauli, Maija Saraste, Marcus Sucksdorff, et al.. (2023). Early prognosticators of later TSPO-PET-measurable microglial activation in multiple sclerosis. Multiple Sclerosis and Related Disorders. 75. 104755–104755. 3 indexed citations
8.
Nylund, Marjo, et al.. (2023). Impact of natalizumab on chronic active lesions (P11-3.011). Neurology. 100(17_supplement_2). 1 indexed citations
9.
Nylund, Marjo, Markus Matilainen, Marcus Sucksdorff, et al.. (2023). Longitudinal stability of progression‐related microglial activity during teriflunomide treatment in patients with multiple sclerosis. European Journal of Neurology. 30(8). 2365–2375. 9 indexed citations
10.
Matilainen, Markus, et al.. (2023). TSPO-Detectable Chronic Active Lesions Predict Disease Progression in Multiple Sclerosis. Neurology Neuroimmunology & Neuroinflammation. 10(5). 16 indexed citations
11.
Saraste, Maija, Markus Matilainen, Cecília Rajda, et al.. (2022). Association between microglial activation and serum kynurenine pathway metabolites in multiple sclerosis patients. Multiple Sclerosis and Related Disorders. 59. 103667–103667. 11 indexed citations
12.
Matilainen, Markus, et al.. (2022). Innate Immune Cell–Related Pathology in the Thalamus Signals a Risk for Disability Progression in Multiple Sclerosis. Neurology Neuroimmunology & Neuroinflammation. 9(4). 17 indexed citations
13.
Saraste, Maija, Markus Matilainen, Marcus Sucksdorff, et al.. (2021). Increased serum glial fibrillary acidic protein associates with microstructural white matter damage in multiple sclerosis. Multiple Sclerosis and Related Disorders. 50. 102810–102810. 34 indexed citations
14.
Jambor, Ivan, M. Pesola, Timo Liimatainen, et al.. (2021). Whole Brain Adiabatic T1rho and Relaxation Along a Fictitious Field Imaging in Healthy Volunteers and Patients With Multiple Sclerosis: Initial Findings. Journal of Magnetic Resonance Imaging. 54(3). 866–879. 1 indexed citations
15.
Tuisku, Jouni, Markus Matilainen, Marjo Nylund, et al.. (2020). Insights into disseminated MS brain pathology with multimodal diffusion tensor and PET imaging. Neurology Neuroimmunology & Neuroinflammation. 7(3). 28 indexed citations
16.
Saraste, Maija, Marcus Sucksdorff, Virva Saunavaara, et al.. (2020). Fingolimod treatment reverses signs of diffuse white matter damage in multiple sclerosis: A pilot study. Multiple Sclerosis and Related Disorders. 48. 102690–102690. 4 indexed citations
17.
Airas, Laura, et al.. (2020). Rituximab in the treatment of multiple sclerosis in the Hospital District of Southwest Finland. Multiple Sclerosis and Related Disorders. 40. 101980–101980. 20 indexed citations
18.
Sucksdorff, Marcus, Markus Matilainen, Jouni Tuisku, et al.. (2020). Brain TSPO-PET predicts later disease progression independent of relapses in multiple sclerosis. Brain. 143(11). 3318–3330. 102 indexed citations
19.
Rissanen, Eero, Jouni Tuisku, Tero Vahlberg, et al.. (2018). Microglial activation, white matter tract damage, and disability in MS. Neurology Neuroimmunology & Neuroinflammation. 5(3). e443–e443. 58 indexed citations
20.
Sucksdorff, Marcus, Eero Rissanen, Jouni Tuisku, et al.. (2017). Evaluation of the Effect of Fingolimod Treatment on Microglial Activation Using Serial PET Imaging in Multiple Sclerosis. Journal of Nuclear Medicine. 58(10). 1646–1651. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marjo Nylund Breakdown of academic impact, for papers by Damiano Marastoni Breakdown of academic impact, for papers by Paul Su Breakdown of academic impact, for papers by Clarisse Carra‐Dallière Breakdown of academic impact, for papers by Etsuji Saji Breakdown of academic impact, for papers by Roumen Balabanov Breakdown of academic impact, for papers by Signe Modvig Breakdown of academic impact, for papers by Dieter Haering Breakdown of academic impact, for papers by Luisa Pastò Breakdown of academic impact, for papers by Miriam Tamaño‐Blanco
Rankless by CCL
2026